Advertisement
AXSM vs BBP
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AXSM is a Hold and BBP is a StrongBuy.
AXSM sees its 50-day moving average cross bearishly below its 200-day moving average
The 50-day moving average for AXSM moved below the 200-day moving average on October 14, 2026. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.
Technical Analysis (Indicators)
Bearish Trend Analysis
The Momentum Indicator moved below the 0 level on September 18, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on AXSM as a result. In 57 of 70 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 81%.
The Moving Average Convergence Divergence Histogram (MACD) for AXSM turned negative on September 23, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 50 similar instances when the indicator turned negative. In 37 of the 50 cases the stock turned lower in the days that followed. This puts the odds of success at 74%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where AXSM declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 77%.
The Aroon Indicator for AXSM entered a downward trend on October 21, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Bullish Trend Analysis
The RSI Indicator shows that the ticker has stayed in the oversold zone for 16 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an Uptrend is expected.
The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 22 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.
AXSM may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
Fundamental Analysis (Ratings)
The Tickeron PE Growth Rating for this company is 16 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 38 (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock slightly better than average.
The Tickeron Price Growth Rating for this company is 64 (best 1 - 100 worst), indicating steady price growth. AXSM’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of 94 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: AXSM's P/B Ratio (98.286) is slightly higher than the industry average of (2.988). P/E Ratio (-41.683) is within average values for comparable stocks, (-1.158). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (9.059). Dividend Yield (0.000) settles around the average of (123.903) among similar stocks. P/S Ratio (13.908) is also within normal values, averaging (438.009).
The Tickeron SMR rating for this company is 100 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
BBP in upward trend: price may ascend as a result of having broken its lower Bollinger Band on October 06, 2026
BBP may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In 39 of 42 cases where BBP's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are 90%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Momentum Indicator moved above the 0 level on October 20, 2026. You may want to consider a long position or call options on BBP as a result. In 80 of 92 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 87%.
The Moving Average Convergence Divergence (MACD) for BBP just turned positive on October 20, 2026. Looking at past instances where BBP's MACD turned positive, the stock continued to rise in 46 of 54 cases over the following month. The odds of a continued upward trend are 85%.
BBP moved above its 50-day moving average on October 20, 2026 date and that indicates a change from a downward trend to an upward trend.
Following a +5.59% 3-day Advance, the price is estimated to grow further. Considering data from situations where BBP advanced for three days, in 279 of 322 cases, the price rose further within the following month. The odds of a continued upward trend are 87%.
Bearish Trend Analysis
The Stochastic Oscillator entered the overbought zone. Expect a price pull-back in the foreseeable future.
The 10-day moving average for BBP crossed bearishly below the 50-day moving average on October 08, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 12 of 14 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 86%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where BBP declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 78%.
The Aroon Indicator for BBP entered a downward trend on October 12, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
AXSM | ||
|---|---|---|
OUTLOOK RATING 1..100 | 50 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 94 Overvalued | |
PROFIT vs RISK RATING 1..100 | 38 | |
SMR RATING 1..100 | 100 | |
PRICE GROWTH RATING 1..100 | 64 | |
P/E GROWTH RATING 1..100 | 16 | |
SEASONALITY SCORE 1..100 | n/a |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
| AXSM | BBP | |
|---|---|---|
| RSI ODDS (%) | 2 days ago 87% | N/A |
| Stochastic ODDS (%) | 2 days ago 81% | 2 days ago 81% |
| Momentum ODDS (%) | 3 days ago 81% | 2 days ago 87% |
| MACD ODDS (%) | 2 days ago 74% | 2 days ago 85% |
| TrendWeek ODDS (%) | 2 days ago 79% | 2 days ago 86% |
| TrendMonth ODDS (%) | 2 days ago 76% | 2 days ago 78% |
| Advances ODDS (%) | N/A | 3 days ago 87% |
| Declines ODDS (%) | 4 days ago 77% | 10 days ago 78% |
| BollingerBands ODDS (%) | 2 days ago 79% | 2 days ago 90% |
| Aroon ODDS (%) | 2 days ago 78% | 2 days ago 79% |
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
AXSM’s FA Score shows that 1 FA rating(s) are green while .
- AXSM’s FA Score: 1 green, 4 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
AXSM’s TA Score shows that 3 TA indicator(s) are bullish.
- AXSM’s TA Score: 3 bullish, 5 bearish.
Price Growth
AXSM (@Biotechnology) experienced а -3.64% price change this weekfor the same time period.
The average weekly price growth across all stocks in the @Biotechnology industry was -1.02%. For the same industry, the average monthly price growth was -18.10%, and the average quarterly price growth was -15.28%.
Reported Earning Dates
AXSM is expected to report earnings on Nov 02, 2026.
Industries' Descriptions
@Biotechnology (-1.02% weekly)Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.
Advertisement
AXSM and
Correlation & Price change
A.I.dvisor indicates that over the last year, AXSM has been loosely correlated with CYTK. These tickers have moved in lockstep 40% of the time. This A.I.-generated data suggests there is some statistical probability that if AXSM jumps, then CYTK could also see price increases.
| Ticker / NAME | Correlation To AXSM | 1D Price Change % | ||
|---|---|---|---|---|
| AXSM | 100% | -2.05% | ||
| CYTK - AXSM | 40% Loosely correlated | -1.70% | ||
| PHVS - AXSM | 40% Loosely correlated | -0.78% | ||
| MIRM - AXSM | 37% Loosely correlated | -1.92% | ||
| RYTM - AXSM | 36% Loosely correlated | -1.75% | ||
| BBIO - AXSM | 36% Loosely correlated | +0.28% | ||
More | ||||
BBP and
Correlation & Price change
A.I.dvisor indicates that over the last year, BBP has been loosely correlated with AXSM. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if BBP jumps, then AXSM could also see price increases.
| Ticker / NAME | Correlation To BBP | 1D Price Change % | ||
|---|---|---|---|---|
| BBP | 100% | -0.82% | ||
| AXSM - BBP | 47% Loosely correlated | -2.05% | ||
| NUVB - BBP | 41% Loosely correlated | +1.68% | ||
| ENTA - BBP | 20% Poorly correlated | -3.08% | ||
| VSTM - BBP | 13% Poorly correlated | -1.39% | ||
| ZLAB - BBP | 9% Poorly correlated | -3.51% | ||
More | ||||
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| DOL | 74.07 | 0.32 | +0.43% |
| WisdomTree True Developed International Fund (DOL) | |||
| RWX | 25.72 | 0.05 | +0.19% |
| State Street SPDR Dow Jones International Real Estate ETF (RWX) | |||
| IGIB | 50.67 | 0.01 | +0.02% |
| iShares 5-10 Year Investment Grade Corporate Bond ETF (IGIB) | |||
| AVGB | 49.92 | -0.05 | -0.10% |
| Avantis Credit ETF (AVGB) | |||
| MCHS | 36.02 | -0.47 | -1.28% |
| Matthews China Innovators Active ETF (MCHS) | |||